OcellO designs co-cultures of cancer and immune cells to test the ability of compounds to potentiate infiltration of immune cells into the tumor and their cytotoxic activity.  PBMCs from healthy donors are the source of immune cells, they are partially HLA-matched with cancer cells. Cellular therapy products (CAR T cells, engineered T cells) provided by customers can also be tested.

Target cells of interest can be selected from OcellO’s collection of established cell lines, PDX or patient derived organoids. In total there are over 300 models available for testing.